The average brokerage recommendation (ABR) for Ares Capital (ARCC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Does Hercules Capital's tech and life sciences focus, rising commitments and stronger earnings outlook give it an edge over Ares Capital? Let's decode.
Zacks.com users have recently been watching Ares Capital (ARCC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.